MedTrace Logo

A Study of Precice Intramedullary Limb Lengthening System (IMLL) Limb Lengthening Procedures

NCT06741514 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-18

No results posted yet for this study

Summary

The Sponsor is conducting a survey to understand how parents or legal guardians feel about the benefits of using the Precice IMLL System to lengthen limbs in children who are 12 years old or younger.

Conditions

  • Limb Length Discrepancy

Interventions

DEVICE

Precice IMLL

Parents or legal guardians of children that previously received the Precice IMLL will complete a survey. No additional or new interventions will be administered.

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Medical Affairs Study Director · Globus Medical Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-25
Primary Completion
2026-07-01
Completion
2026-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06741514 on ClinicalTrials.gov